Candesartan

Candesartan is an inhibitor of the angiotensin II type 1 receptor (AT1) that displays antihypertensive, cardioprotective, nephroprotective, and potentially antiviral activities. In vivo, candesartan increases renal blood blow and decreases renal

Candesartan is an inhibitor of the angiotensin II type 1 receptor (AT1) that displays antihypertensive, cardioprotective, nephroprotective, and potentially antiviral activities. In vivo, candesartan increases renal blood blow and decreases renal

Candesartan is an inhibitor of the angiotensin II type 1 receptor (AT1) that displays antihypertensive, cardioprotective, nephroprotective, and potentially antiviral activities. In vivo, candesartan increases renal blood blow and decreases renal

Candesartan is an inhibitor of the angiotensin II type 1 receptor (AT1) that displays antihypertensive, cardioprotective, nephroprotective, and potentially antiviral activities. In vivo, candesartan increases renal blood blow and decreases renal

Candesartan is an inhibitor of the angiotensin II type 1 receptor (AT1) that displays antihypertensive, cardioprotective, nephroprotective, and potentially antiviral activities. In vivo, candesartan increases renal blood blow and decreases renal

Candesartan is an inhibitor of the angiotensin II type 1 receptor (AT1) that displays antihypertensive, cardioprotective, nephroprotective, and potentially antiviral activities. In vivo, candesartan increases renal blood blow and decreases renal

Candesartan is an angiotensin II receptor antagonist with IC50 of 0.26 nM.A selective angiotensin II receptor antagonist.Application：CAN may be used as a pharmaceutical reference standard for the determination of the analyte in pharmaceutical

Candesartan is an angiotensin II receptor antagonist with IC50 of 0.26 nM.A selective angiotensin II receptor antagonist.Application：CAN may be used as a pharmaceutical reference standard for the determination of the analyte in pharmaceutical

Candesartan is an angiotensin II receptor antagonist with IC50 of 0.26 nM.A selective angiotensin II receptor antagonist.Application：CAN may be used as a pharmaceutical reference standard for the determination of the analyte in pharmaceutical

Candesartan is an angiotensin II receptor antagonist with IC50 of 0.26 nM.A selective angiotensin II receptor antagonist.Application：CAN may be used as a pharmaceutical reference standard for the determination of the analyte in pharmaceutical

InformationCandesartan (CV-11974) Candesartan (CV-11974) is an angiotensin II receptor antagonist with IC50 of 0.26 nM.In vitroCandesartan binds with high specificity to the angiotensin II AT1 receptors in CHO-AT1 cells with K−1 of 0.001 min−1.

Candesartan Ethyl Ester is a candesartan analog that is an angiotensin II receptor antagonist.